Signature of molnupiravir might be in SARS-CoV-2 genomic sequence. Plus, the everyday chemicals that make us fatter and codebreakers decrypt the long-lost letters of Mary, Queen of Scots. COVID drug might drive viral mutations Molnupiravir, a drug widely used to treat COVID-19, might be spurring the evolution of new SARS-CoV-2...
Could a popular COVID-19 antiviral supercharge the pandemic?
A worker handles a bottle of Merck & Co. and Ridgeback Biotherapeutics LPs Molnupiravir antiviral medication in a warehouse in Shoham, Israel, on Jan. 18, 2022. A fourth dose of the Pfizer-BioNTech vaccine was insufficient to prevent infection with the omicron variant of Covid-19, according to preliminary data from a trial...
Oxidative DNA Damage by N4-hydroxycytidine, a Metabolite of the SARS-CoV-2 Antiviral Molnupiravir
Hatasu Kobayashi 1, Yurie Mori 2,3, Sharif Ahmed 4, Yuichiro Hirao 5,6, Shinya Kato 7, Shosuke Kawanishi 8, Mariko Murata 9, Shinji Oikawa 10,✉,2 Author information Article notes Copyright and License information PMCID: PMC10132762 PMID: 36461940 Abstract Molnupiravir is an antiviral agent recently used for treating coronavirus disease 2019 (COVID-19). Here, we demonstrate that N4-hydroxycytidine (NHC), a molnupiravir metabolite, treated with cytidine deaminase (CDA) induced Cu(II)-mediated oxidative DNA...
Lethal Mutagenesis of RNA Viruses and Approved Drugs with Antiviral Mutagenic Activity
Ikbel Hadj Hassine 1, Manel Ben M'hadheb 1, Luis Menéndez-Arias 2 Affiliations Expand PMID: 35458571 PMCID: PMC9024455 DOI: 10.3390/v14040841 Abstract In RNA viruses, a small increase in their mutation rates can be sufficient to exceed their threshold of viability. Lethal mutagenesis is a therapeutic strategy based on the use of mutagens, driving viral populations to extinction. Extinction catastrophe can...
Human genetic risk of treatment with antiviral nucleoside analog drugs that induce lethal mutagenesis: The special case of molnupiravir
Michael D Waters 1, Stafford Warren 2, Claude Hughes 3, Philip Lewis 4, Fengyu Zhang 5 Affiliations Expand PMID: 35023215 DOI: 10.1002/em.22471 Abstract This review considers antiviral nucleoside analog drugs, including ribavirin, favipiravir, and molnupiravir, which induce genome error catastrophe in SARS-CoV or SARS-CoV-2 via lethal mutagenesis as a mode of action. In vitro data indicate that molnupiravir may be 100 times...
Merck’s Covid Pill Might Pose Risks for Pregnant Women
Some laboratory studies suggest that molnupiravir can insert errors in DNA, which could in theory harm a developing fetus, sperm cells or children. While molnupiravir has been shown to reduce the risk of hospitalization and death from Covid-19, scientists have raised concerns about the drug’s potential to cause mutations in...
β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells
Shuntai Zhou 1, Collin S Hill 1, Sanjay Sarkar 2, Longping V Tse 3, Blaide M D Woodburn 1 4, Raymond F Schinazi 5, Timothy P Sheahan 3, Ralph S Baric 3 6, Mark T Heise 2 6, Ronald Swanstrom 1 7 Affiliations Expand PMID: 33961695 PMCID: PMC8136050 DOI: 10.1093/infdis/jiab247 Abstract Mutagenic ribonucleosides can act as broad-based antiviral agents. They are metabolized to the active ribonucleoside triphosphate form and concentrate in genomes of RNA viruses during viral...